Efgartigimod Outperforms Standard IVIG in Averting Myasthenic Crisis

First-line efgartigimod could soon be more than a hypothetical therapeutic option for patients with acetylcholine receptor antibody-positive myasthenia gravis who appear to be heading toward myasthenic crisis, according to new data published in